arginine vasopressin has been researched along with tacrolimus in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Eckert, B; Knepel, W; Schwaninger, M | 1 |
| Thomas, M; Tyagi, MG | 1 |
| Brandis, M; Epting, T; Fischer-Riepe, P; Gordjani, N; Greger, RF; Leipziger, J; Nitschke, R | 1 |
| Hassan, A; Mason, D | 1 |
1 review(s) available for arginine vasopressin and tacrolimus
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 other study(ies) available for arginine vasopressin and tacrolimus
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Calcium-mobilizing insulin secretagogues stimulate transcription that is directed by the cyclic adenosine 3',5'-monophosphate/calcium response element in a pancreatic islet beta-cell line.
Topics: Animals; Arginine Vasopressin; Biological Transport; Calcium; Cell Line; Cricetinae; Cyclic AMP Response Element-Binding Protein; Cyclosporine; Insulin; Insulin Secretion; Islets of Langerhans; Phosphorylation; Tacrolimus; Transcription, Genetic | 1996 |
Enhanced cardiovascular reactivity to desmopressin in water-restricted rats: facilitatory role of immunosuppression.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Cardiovascular System; Cyclosporine; Deamino Arginine Vasopressin; Dose-Response Relationship, Drug; Drug Synergism; Heart Rate; Hemodynamics; Immunosuppression Therapy; Immunosuppressive Agents; Infusions, Intra-Arterial; Infusions, Intravenous; Rats; Tacrolimus; Time Factors; Water Deprivation | 1999 |
Cyclosporin-A-induced effects on the free Ca2+ concentration in LLC-PK1-cells and their mechanisms.
Topics: Adenosine Triphosphate; Animals; Arginine Vasopressin; Biological Transport; Calcineurin Inhibitors; Calcium; Cyclosporine; Estrenes; Fluorescent Dyes; Fura-2; Immunosuppressive Agents; Inositol 1,4,5-Trisphosphate; Kidney Tubules, Proximal; LLC-PK1 Cells; Nicardipine; Phosphodiesterase Inhibitors; Pyrrolidinones; Renal Agents; Signal Transduction; Swine; Tacrolimus; Type C Phospholipases; Vasodilator Agents | 2000 |
Mechanisms of desensitization of the adrenocorticotropin response to arginine vasopressin in ovine anterior pituitary cells.
Topics: Adrenocorticotropic Hormone; Animals; Arginine Vasopressin; Calcineurin Inhibitors; Casein Kinase I; Cells, Cultured; Concanavalin A; Diglycerides; Dose-Response Relationship, Drug; Indoles; Okadaic Acid; Phosphoprotein Phosphatases; Pituitary Gland, Anterior; Protein Kinase C; Protein Phosphatase 1; Protein Phosphatase 2; Receptors, Vasopressin; Sheep; Stimulation, Chemical; Tacrolimus; Time Factors | 2005 |